These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 24393522)

  • 1. Completeness and timeliness: Cancer registries could/should improve their performance.
    Zanetti R; Schmidtmann I; Sacchetto L; Binder-Foucard F; Bordoni A; Coza D; Ferretti S; Galceran J; Gavin A; Larranaga N; Robinson D; Tryggvadottir L; Van Eycken E; Zadnik V; Coebergh JW; Rosso S
    Eur J Cancer; 2015 Jun; 51(9):1091-8. PubMed ID: 24393522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EUROCOURSE recipe for cancer surveillance by visible population-based cancer RegisTrees in Europe: From roots to fruits.
    Coebergh JW; van den Hurk C; Louwman M; Comber H; Rosso S; Zanetti R; Sacchetto L; Storm H; van Veen EB; Siesling S; van den Eijnden-van Raaij J
    Eur J Cancer; 2015 Jun; 51(9):1050-63. PubMed ID: 25934439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Data quality at the Icelandic Cancer Registry: comparability, validity, timeliness and completeness.
    Sigurdardottir LG; Jonasson JG; Stefansdottir S; Jonsdottir A; Olafsdottir GH; Olafsdottir EJ; Tryggvadottir L
    Acta Oncol; 2012 Sep; 51(7):880-9. PubMed ID: 22974093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of completeness of case ascertainment of Austrian cancer incidence data using the flow method.
    Hackl M; Waldhoer T
    Eur J Public Health; 2013 Oct; 23(5):889-93. PubMed ID: 23002230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EUROCOURSE lessons learned from and for population-based cancer registries in Europe and their programme owners: Improving performance by research programming for public health and clinical evaluation.
    Coebergh JW; van den Hurk C; Rosso S; Comber H; Storm H; Zanetti R; Sacchetto L; Janssen-Heijnen M; Thong M; Siesling S; van den Eijnden-van Raaij J
    Eur J Cancer; 2015 Jun; 51(9):997-1017. PubMed ID: 25956208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Data quality at the Bulgarian National Cancer Registry: An overview of comparability, completeness, validity and timeliness.
    Dimitrova N; Parkin DM
    Cancer Epidemiol; 2015 Jun; 39(3):405-13. PubMed ID: 25914137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How do cancer registries in europe estimate completeness of registration?
    Schmidtmann I; Blettner M
    Methods Inf Med; 2009; 48(3):267-71. PubMed ID: 19387506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Index for evaluating completeness of registration in population-based cancer registries and estimation of registration rate at the Osaka Cancer Registry between 1966 and 1992 using this index].
    Ajiki W; Tsukuma H; Oshima A
    Nihon Koshu Eisei Zasshi; 1998 Oct; 45(10):1011-7. PubMed ID: 9893469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Data quality at population-based cancer registries in Colombia.
    Cendales R; Pardo C; Uribe C; López G; Yepez MC; Bravo LE
    Biomedica; 2012; 32(4):536-44. PubMed ID: 23715229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Completeness of a newly implemented general cancer registry in northern France: Application of a three-source capture-recapture method.
    Plouvier SD; Bernillon P; Ligier K; Theis D; Miquel PH; Pasquier D; Rivest LP
    Rev Epidemiol Sante Publique; 2019 Jul; 67(4):239-245. PubMed ID: 31146902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Completeness of ascertainment by cancer registries: putting bounds on the number of missing cases.
    Silcocks PB; Robinson D
    J Public Health (Oxf); 2004 Jun; 26(2):161-7. PubMed ID: 15284320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The completeness and timeliness of cancer registration and the implications for measuring cancer burden.
    Donnelly C; Cairnduff V; Chen JJ; Kearney T; Fitzpatrick D; Fox C; Gavin A
    Cancer Epidemiol; 2017 Aug; 49():101-107. PubMed ID: 28600946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating Difficult Decisions in Public Health Surveillance: Striking the Right Balance between Timeliness and Completeness.
    Salemi JL; Tanner JP; Anjohrin SB; Rutkowski RE; Correia JA; Watkins SM; Kirby RS
    J Registry Manag; 2015; 42(2):48-61. PubMed ID: 26360106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surveillance Evaluation of the National Cancer Registry in Sabah, Malaysia.
    Jeffree SM; Mihat O; Lukman KA; Ibrahim MY; Kamaludin F; Hassan MR; Kaur N; Myint T
    Asian Pac J Cancer Prev; 2016; 17(7):3123-9. PubMed ID: 27509940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of data quality at the Gambia national cancer registry.
    Shimakawa Y; Bah E; Wild CP; Hall AJ
    Int J Cancer; 2013 Feb; 132(3):658-65. PubMed ID: 22618962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Completeness of regional cancer registry data in Northwest Russia 2008-2017.
    Barchuk A; Tursun-Zade R; Nazarova E; Komarov Y; Tyurina E; Tumanova Y; Belyaev A; Znaor A
    BMC Cancer; 2023 Oct; 23(1):994. PubMed ID: 37853404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating completeness in cancer registries--comparing capture-recapture methods in a simulation study.
    Schmidtmann I
    Biom J; 2008 Dec; 50(6):1077-92. PubMed ID: 19067337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Data quality at the Singapore Cancer Registry: An overview of comparability, completeness, validity and timeliness.
    Fung JW; Lim SB; Zheng H; Ho WY; Lee BG; Chow KY; Lee HP
    Cancer Epidemiol; 2016 Aug; 43():76-86. PubMed ID: 27399312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of data quality in the cancer registry: principles and methods Part II. Completeness.
    Parkin DM; Bray F
    Eur J Cancer; 2009 Mar; 45(5):756-64. PubMed ID: 19128954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of data quality in the cancer registry: principles and methods. Part I: comparability, validity and timeliness.
    Bray F; Parkin DM
    Eur J Cancer; 2009 Mar; 45(5):747-55. PubMed ID: 19117750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.